BAVA:VIE
Bavarian Nordic A/S
€ 31.50
0.00%
(0.00) Siku 1
14 Okt, 17:32:09 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BAVA...
Mtaji wa soko
2.77B
Wastani wa kiasi cha mauzo
17.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 32.47
Chini kwa wiki 52
€ 22.96
Idadi ya wafanyakazi
elfu 2
Mtaji wa soko
2.77B
Wastani wa kiasi cha mauzo
17.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 32.47
Chini kwa wiki 52
€ 22.96
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
GlobeNewswire
·
siku 2 zilizopita
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Wasifu
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Kuhusu Bavarian Nordic A/S
Afisa Mkuu Mtendaji (CEO)Paul Chaplin
Wafanyakazielfu 1.91
Lilianzishwa1 Jul 1992
Makao makuu-
Sekta-
Tovutibavarian-nordic.com